Biostar Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2016
Biostar Pharmaceuticals, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2016. For the quarter, the company reported sales of $801,627 against $6,908,747 a year ago. Loss from operations was $668,518 against $889,998 a year ago. Loss before income taxes was $678,566 against $638,975 a year ago. Net loss was $620,341 or $0.28 per basic and diluted share against $160,104 or $0.07 per basic and diluted share a year ago. Net cash provided by operating activities was $342,822 against $2,835,026 a year ago.